MC2 Therapeutics A/S
CVR number: 29526346
Agern Alle 24-26, 2970 Hørsholm
tel: 20181111
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 13 678.38 | 15 938.17 | 27 734.44 | 24 451.63 | 26 355.18 |
| Employee benefit expenses | -14 067.56 | -14 706.09 | -26 007.01 | -22 599.36 | -24 444.88 |
| Total depreciation | - 216.28 | - 244.60 | - 275.52 | - 224.70 | - 240.74 |
| EBIT | - 605.45 | 987.48 | 1 451.91 | 1 627.57 | 1 669.55 |
| Other financial income | 6 646.26 | 9 524.50 | 5 488.66 | 2 052.36 | 7 714.57 |
| Other financial expenses | -81.24 | -2 616.44 | -3 177.58 | -8 303.12 | -19 204.39 |
| Net income from associates (fin.) | -87 231.68 | -94 965.27 | -28 985.94 | -96 708.07 | -32 030.90 |
| Pre-tax profit | -81 272.11 | -87 069.73 | -25 222.96 | - 101 331.26 | -41 851.17 |
| Income taxes | - 129.08 | 129.08 | |||
| Net earnings | -81 401.18 | -86 940.65 | -25 222.96 | - 101 331.26 | -41 851.17 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 57.88 | 27.68 | |||
| Intangible assets total | 57.88 | 27.68 | |||
| Buildings | 44.16 | 53.32 | 146.94 | 106.67 | 135.91 |
| Machinery and equipment | 723.15 | 527.60 | 406.71 | 222.28 | 70.12 |
| Tangible assets total | 767.31 | 580.92 | 553.65 | 328.95 | 206.03 |
| Holdings in group member companies | 54.45 | 82.25 | 46 431.52 | 25 696.19 | 11 804.82 |
| Other receivables | 181.37 | 181.37 | 271.58 | 271.58 | 444.00 |
| Investments total | 235.82 | 263.62 | 46 703.10 | 25 967.77 | 12 248.82 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 78 612.37 | 26 380.74 | 1 096.65 | 9 267.02 | 15 439.87 |
| Prepayments and accrued income | 90.18 | 158.18 | 899.12 | 629.34 | 762.51 |
| Current other receivables | 204.90 | 929.09 | 884.17 | 1 591.57 | 1 005.46 |
| Short term receivables total | 78 907.44 | 27 468.01 | 2 879.94 | 11 487.94 | 17 207.84 |
| Cash and bank deposits | 26 641.73 | 7 804.66 | 1 465.82 | 807.69 | 925.99 |
| Cash and cash equivalents | 26 641.73 | 7 804.66 | 1 465.82 | 807.69 | 925.99 |
| Balance sheet total (assets) | 106 610.19 | 36 144.89 | 51 602.51 | 38 592.34 | 30 588.69 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 6 561.61 | 6 611.48 | 6 611.48 | 6 611.48 | 6 611.48 |
| Other reserves | 153.68 | ||||
| Retained earnings | 140 672.07 | 94 259.35 | -2 486.11 | -28 083.85 | - 129 294.17 |
| Profit of the financial year | -81 401.18 | -86 940.65 | -25 222.96 | - 101 331.26 | -41 851.17 |
| Shareholders equity total | 65 832.50 | 13 930.18 | -21 097.59 | - 122 649.95 | - 164 533.85 |
| Provisions | 9 372.51 | 9 481.99 | |||
| Non-current owed to group member | 19 131.81 | 156 317.29 | 189 574.61 | ||
| Non-current deferred tax liabilities | 423.84 | 1 058.19 | 914.13 | 837.61 | 873.92 |
| Non-current liabilities total | 423.84 | 1 058.19 | 20 045.94 | 157 154.90 | 190 448.53 |
| Current loans from credit institutions | 33.48 | 111.81 | |||
| Current trade creditors | 1 313.68 | 1 912.87 | 2 408.97 | 2 028.72 | 1 751.52 |
| Current owed to participating | 6 057.60 | ||||
| Current owed to group member | 27 762.13 | 1 261.49 | 48 124.13 | 1 243.34 | 1 490.41 |
| Short-term deferred tax liabilities | 129.08 | ||||
| Other non-interest bearing current liabilities | 1 742.98 | 2 330.76 | 2 121.05 | 815.34 | 1 432.08 |
| Current liabilities total | 30 981.34 | 11 674.53 | 52 654.16 | 4 087.39 | 4 674.01 |
| Balance sheet total (liabilities) | 106 610.19 | 36 144.89 | 51 602.51 | 38 592.34 | 30 588.69 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.